Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roceso Technologies’ products are commercially available in over thirty countries. Their flagship product line—EsoGLOVE—has been adopted for clinical use in neurorehabilitation centers globally. The company’s digital health platforms enable remote monitoring and therapy but no clinical trial results are publicly reported; the devices are used both in clinics and at home for ongoing rehabilitation of hand/upper limb function after neurological injury.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roceso Technologies.